Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lignosus rhinocerus, commonly known as the Tiger Milk Mushroom, is a medicinal mushroom from the Polyporaceae family, traditionally used in Southeast Asia for a variety of ailments, including cough, asthma, cancer, and fever. [0] Scientific research, particularly on the cultivated TM02 strain, has explored its immunomodulatory, anti-inflammatory, anti-angiogenic, and anti-tumor properties. [0] The sclerotium (a compact mass of hardened fungal mycelium) is the part used for medicinal purposes. [0] A hot-water extract has shown anti-tumor and anti-angiogenic activities in preclinical cancer models. [0] A Phase II clinical trial is evaluating its use as a complementary therapy for uncontrolled asthma, with the goal of reducing airway inflammation and improving symptoms. [0] It is marketed as a health supplement, with one product being "Tigerus Tiger Milk Mushroom Sclerotia". [0]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lignosus rhinocerus.